6,600 Shares in Ventas, Inc. $VTR Acquired by ARQ Wealth Advisors LLC

ARQ Wealth Advisors LLC bought a new stake in Ventas, Inc. (NYSE:VTR) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 6,600 shares of the real estate investment trust’s stock, valued at approximately $462,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Norges Bank bought a new stake in Ventas during the second quarter valued at $344,740,000. Vanguard Group Inc. raised its position in shares of Ventas by 4.1% in the 2nd quarter. Vanguard Group Inc. now owns 71,796,312 shares of the real estate investment trust’s stock worth $4,533,937,000 after acquiring an additional 2,854,751 shares in the last quarter. UBS Group AG lifted its stake in Ventas by 142.4% in the third quarter. UBS Group AG now owns 3,507,841 shares of the real estate investment trust’s stock valued at $245,514,000 after buying an additional 2,060,770 shares during the period. Citigroup Inc. lifted its position in shares of Ventas by 451.9% during the 2nd quarter. Citigroup Inc. now owns 2,316,344 shares of the real estate investment trust’s stock valued at $146,277,000 after acquiring an additional 1,896,627 shares during the period. Finally, Lasalle Investment Management Securities LLC boosted its position in shares of Ventas by 1,135.1% during the 3rd quarter. Lasalle Investment Management Securities LLC now owns 1,552,880 shares of the real estate investment trust’s stock worth $108,686,000 after purchasing an additional 1,427,151 shares in the last quarter. Institutional investors own 94.18% of the company’s stock.

Ventas Trading Up 0.2%

NYSE:VTR opened at $87.94 on Wednesday. The company has a 50-day moving average price of $81.92 and a 200-day moving average price of $76.73. The stock has a market cap of $41.77 billion, a price-to-earnings ratio of 162.86, a P/E/G ratio of 2.17 and a beta of 0.73. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.03. Ventas, Inc. has a 12 month low of $60.15 and a 12 month high of $88.23.

Ventas (NYSE:VTR) last announced its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.89 by ($0.74). Ventas had a net margin of 4.31% and a return on equity of 2.09%. The company had revenue of ($1,229.71) million for the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter in the prior year, the firm earned $0.81 EPS. Ventas’s quarterly revenue was up 21.7% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities analysts predict that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.52 per share. This is an increase from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, March 31st. Ventas’s payout ratio is 355.56%.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. Wells Fargo & Company lifted their price target on shares of Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Jefferies Financial Group restated a “buy” rating and set a $93.00 price target on shares of Ventas in a research report on Monday, December 15th. The Goldman Sachs Group reiterated a “buy” rating and issued a $100.00 target price on shares of Ventas in a research note on Monday, February 9th. KeyCorp boosted their price objective on Ventas from $85.00 to $90.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Finally, Argus set a $88.00 price objective on Ventas in a research note on Tuesday, February 10th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $89.00.

Insider Buying and Selling at Ventas

In related news, CEO Debra A. Cafaro sold 10,322 shares of the stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the completion of the transaction, the chief executive officer directly owned 1,114,034 shares in the company, valued at $86,515,880.44. This trade represents a 0.92% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Robert F. Probst sold 29,930 shares of Ventas stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the transaction, the chief financial officer directly owned 138,434 shares of the company’s stock, valued at approximately $10,694,026.50. This trade represents a 17.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 86,106 shares of company stock valued at $6,931,397. 1.00% of the stock is currently owned by company insiders.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.